drugset / Trial / NCT04922918
Ligilactobacillus Salivarius MP101 for Elderly in a Nursing Home
NaSingle-groupOpen-labelSupportive care
Summary
The objective of this work was to investigate the effect of Ligilactobacillus salivarius MP101 on the functional (Barthel index), cognitive (GDS/FAST) and nutritional (MNA) status, and on the nasal and fecal inflammatory profiles of elderly living in a nursing home highly affected by COVID-19.
Timeline
- Start
- 2020-10-01
- Primary completion
- 2021-06-24
- Completion
- 2021-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ligilactobacillus salivarius MP101 | Other / unclassified | 9 unknown | Oral |